Cancer Treatment Reviews
Volume 36, Issue 2 , Pages 157-163, April 2010

Approach to radiation therapy in hepatocellular carcinoma

  • Shumei Ma

      Affiliations

    • Key Laboratory of Radiobiology (Ministry of Health), School of Public Health, Jilin University, Changchun 130021, China
  • ,
  • Benzheng Jiao

      Affiliations

    • Key Laboratory of Radiobiology (Ministry of Health), School of Public Health, Jilin University, Changchun 130021, China
  • ,
  • Xin Liu

      Affiliations

    • Key Laboratory of Radiobiology (Ministry of Health), School of Public Health, Jilin University, Changchun 130021, China
  • ,
  • Heqing Yi

      Affiliations

    • Key Laboratory of Radiobiology (Ministry of Health), School of Public Health, Jilin University, Changchun 130021, China
  • ,
  • Dejuan Kong

      Affiliations

    • Key Laboratory of Radiobiology (Ministry of Health), School of Public Health, Jilin University, Changchun 130021, China
  • ,
  • Lin Gao

      Affiliations

    • Key Laboratory of Radiobiology (Ministry of Health), School of Public Health, Jilin University, Changchun 130021, China
  • ,
  • Guangtong Zhao

      Affiliations

    • Key Laboratory of Radiobiology (Ministry of Health), School of Public Health, Jilin University, Changchun 130021, China
  • ,
  • Yu Yang

      Affiliations

    • Dept. of Oncology, 2nd Hospital Affiliated to Harbin Medical University, Harbin 150086, China
    • Corresponding Author InformationCorresponding authors. Address: Key Laboratory of Radiobiology (Ministry of Health), School of Public Health, Jilin University, Changchun 130021, China. Tel.: +86 431 85619418; fax: +86 431 85619431 (X. Liu).
  • ,
  • Xiaodong Liu

      Affiliations

    • Key Laboratory of Radiobiology (Ministry of Health), School of Public Health, Jilin University, Changchun 130021, China
    • Dept. of Radiation Oncology, China–Japan Union Hospital, Changchun 130021, China
    • Corresponding Author InformationCorresponding authors. Address: Key Laboratory of Radiobiology (Ministry of Health), School of Public Health, Jilin University, Changchun 130021, China. Tel.: +86 431 85619418; fax: +86 431 85619431 (X. Liu).

Received 28 July 2009; received in revised form 16 November 2009; accepted 29 November 2009. published online 25 December 2009.

Summary 

Hepatocellular carcinoma (HCC), the 5th most common cancer and the third most common cause of cancer-related death in the world with an estimated incidence of proximately 1 million new cases annually, has becoming a major global health problem in the world. A variety of treatment modalities, including resection, liver transplantation, transarterial chemoembolization (TACE), local ablative therapy and radiation therapy (RT) have been reported. Although partial hepatectomy and liver transplantation may offer the best chance of cure, only 15% of the patients have the chance to be treated by surgery when diagnosed. The effectiveness of systemic chemotherapy for HCC has been minimal, and local ablative therapy may offer comparable survival in patients with small HCC and preserve liver function. Recently, with developments in radiotherapy techniques, radiotherapy has been shown to play potential roles in a wide spectrum of HCC and to become more important so that it is necessary to evaluate the effect of radiotherapy in treatment of HCC. This paper is aiming mainly at the current radiation therapy strategies and their current advances, the optimal radiation therapy strategies will complement the current treatments and improve the treatment efficiency.

Keywords: Radiation therapy, Hepatocellular carcinoma, 3D-CRT, SRT, TACE

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0305-7372(09)00182-0

doi:10.1016/j.ctrv.2009.11.008

Cancer Treatment Reviews
Volume 36, Issue 2 , Pages 157-163, April 2010